Related content

Protective effect of a GRK5 polymorphismon heart failure and its interaction with &bgr;β-adrenergic receptor antagonists

By Eijgelsheim Mark   Visser Loes E   Uitterlinden Andréé G   Stricker Bruno H Ch  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1551-1555

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of the response to &bgr;β2 agonist drugs: a systematic overview of the field

By Contopoulos-Ioannidis Despina G   Kouri Ioanna   Ioannidis John PA  

Pharmacogenomics, Vol. 8, Iss. 8, 2007-08 ,pp. : 933-958

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of &bgr;β₂-agonist: key focus on signaling pathways

By Bhatnagar Pallav   Guleria Randeep   Kukreti Ritushree  

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 919-933

Future Medicine

Access to resources Recommend Favorite

Blockade of dopamine transporter and tyrosine hydroxylase activity loss by [d-Ala 2 , d-Leu 5 ]enkephalin in methamphetamine-treated CD-1 mice

By Tsao L.-I.   Hayashi T.   Su T.-P.  

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 89-93

Elsevier

Access to resources Recommend Favorite

Blockade of MK-801-Induced Heat Shock Protein 72/73 in Rat Brain by Antipsychotic and Monoaminergic Agents Targeting D2, 5-HT1A, 5-HT2A and 1-Adrenergic Receptors

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-02 ,pp. : 104-111

Bentham Science Publishers

Access to resources Recommend Favorite